DE69427648T2 - Verfahren zur herstellung einer clodronat-zubereitung - Google Patents

Verfahren zur herstellung einer clodronat-zubereitung

Info

Publication number
DE69427648T2
DE69427648T2 DE69427648T DE69427648T DE69427648T2 DE 69427648 T2 DE69427648 T2 DE 69427648T2 DE 69427648 T DE69427648 T DE 69427648T DE 69427648 T DE69427648 T DE 69427648T DE 69427648 T2 DE69427648 T2 DE 69427648T2
Authority
DE
Germany
Prior art keywords
clodronate
pct
tetrahydrate
disodium
disodium clodronate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69427648T
Other languages
English (en)
Other versions
DE69427648D1 (de
Inventor
Esko Pohjala
Heikki Nupponen
Kari Lehmussaari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Oy
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Application granted granted Critical
Publication of DE69427648D1 publication Critical patent/DE69427648D1/de
Publication of DE69427648T2 publication Critical patent/DE69427648T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
DE69427648T 1993-11-12 1994-11-11 Verfahren zur herstellung einer clodronat-zubereitung Expired - Fee Related DE69427648T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI935019A FI94926C (fi) 1993-11-12 1993-11-12 Menetelmä klodronaattivalmisteen valmistamiseksi
PCT/FI1994/000509 WO1995013054A1 (en) 1993-11-12 1994-11-11 Process for preparing a clodronate preparation

Publications (2)

Publication Number Publication Date
DE69427648D1 DE69427648D1 (de) 2001-08-09
DE69427648T2 true DE69427648T2 (de) 2002-04-18

Family

ID=8538945

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69427648T Expired - Fee Related DE69427648T2 (de) 1993-11-12 1994-11-11 Verfahren zur herstellung einer clodronat-zubereitung

Country Status (25)

Country Link
US (1) US5776499A (de)
EP (1) EP0727983B1 (de)
JP (1) JPH09504800A (de)
KR (1) KR100352155B1 (de)
CN (1) CN1040945C (de)
AT (1) ATE202700T1 (de)
AU (1) AU679586B2 (de)
CA (1) CA2175994A1 (de)
CZ (1) CZ286132B6 (de)
DE (1) DE69427648T2 (de)
DK (1) DK0727983T3 (de)
ES (1) ES2160688T3 (de)
FI (1) FI94926C (de)
GR (1) GR3036470T3 (de)
HU (1) HU220633B1 (de)
IL (1) IL111596A (de)
NO (1) NO312938B1 (de)
NZ (1) NZ275833A (de)
PL (1) PL176658B1 (de)
PT (1) PT727983E (de)
RU (1) RU2141323C1 (de)
SK (1) SK280552B6 (de)
TW (1) TW436297B (de)
WO (1) WO1995013054A1 (de)
ZA (1) ZA948974B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
DE19808634A1 (de) * 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
AR021347A1 (es) 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
RO121891B1 (ro) 2001-07-04 2008-07-30 Sindan S.R.L. Compoziţie farmaceutică pentru profilaxia şi tratamentul dereglărilor metabolismului calciului şi procedeu de preparare
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
GB0616794D0 (en) 2006-08-24 2006-10-04 Arrow Int Ltd Solid dosage form
CN108472703B (zh) * 2015-12-22 2021-01-01 切佩茨基机械厂股份公司 使用钛合金制造棒材的方法
BR112020010192A2 (pt) 2017-11-22 2020-10-13 Inbiomotion S.L. tratamento terapêutico de câncer de mama com base no status de c-maf
TWI806467B (zh) 2022-03-03 2023-06-21 金兆豐數位科技股份有限公司 金融商品提昇報酬率多維度決策方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE60711T1 (de) 1986-12-20 1991-02-15 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
DE59300688D1 (de) * 1993-05-15 1995-11-02 Boehringer Mannheim Gmbh Tablette mit verbesserter Bioverfügbarkeit enthaltend Dichlormethylendiphosphonsäure als Wirkstoff.

Also Published As

Publication number Publication date
AU679586B2 (en) 1997-07-03
ZA948974B (en) 1995-11-21
KR960705548A (ko) 1996-11-08
PL314299A1 (en) 1996-09-02
CZ132796A3 (en) 1996-10-16
DK0727983T3 (da) 2001-09-24
PT727983E (pt) 2001-11-30
FI935019A0 (fi) 1993-11-12
FI935019A (fi) 1995-05-13
FI94926B (fi) 1995-08-15
CA2175994A1 (en) 1995-05-18
SK60696A3 (en) 1997-02-05
KR100352155B1 (ko) 2002-12-31
US5776499A (en) 1998-07-07
NO961906L (no) 1996-05-23
TW436297B (en) 2001-05-28
RU2141323C1 (ru) 1999-11-20
EP0727983A1 (de) 1996-08-28
GR3036470T3 (en) 2001-11-30
CZ286132B6 (cs) 2000-01-12
EP0727983B1 (de) 2001-07-04
PL176658B1 (pl) 1999-07-30
HUT75228A (en) 1997-04-28
WO1995013054A1 (en) 1995-05-18
NO961906D0 (no) 1996-05-10
IL111596A0 (en) 1995-01-24
NZ275833A (en) 1997-10-24
CN1040945C (zh) 1998-12-02
DE69427648D1 (de) 2001-08-09
JPH09504800A (ja) 1997-05-13
ATE202700T1 (de) 2001-07-15
CN1134664A (zh) 1996-10-30
IL111596A (en) 1998-12-06
SK280552B6 (sk) 2000-03-13
FI94926C (fi) 1995-11-27
HU9601257D0 (en) 1996-07-29
AU8108794A (en) 1995-05-29
NO312938B1 (no) 2002-07-22
ES2160688T3 (es) 2001-11-16
HU220633B1 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
ATE183641T1 (de) Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen
AU8732791A (en) Starting material for the production of bone cement, process for producing the same and process for producing bone cement
DE69112463D1 (de) Vorrichtung zur Herstellung von Monokristallen nach dem Czochralski-Verfahren.
NO971965D0 (no) Farmasöytisk preparat inneholdende en smeltbar bærer og fremgangsmåte for fremstilling derav
MX9101645A (es) Mejoras en o relativas a moldes dispersables en agua
HUT52025A (en) Insecticide compositions containing cyclopropyl-substituted diaryl compounds as active component and process for producing the active components
DE69017642D1 (de) Vorrichtung zur Herstellung von Einkristallen nach dem Czochralski-Verfahren.
DE69427648T2 (de) Verfahren zur herstellung einer clodronat-zubereitung
DE59402607D1 (de) Verfahren zur herstellung von granulaten
DE69104365T2 (de) Vaterit und verfahren zu dessen herstellung.
ATE161423T1 (de) Verwendung von phosphinate zur behandlung der osteoporose
NO960972L (no) Leirdue og en fremgangsmåte for fremstilling av denne
DE69108007T2 (de) Verfahren zur herstellung einer einen wärme-, licht- und feuchtigkeit empfindlichen wirkstoff mit einer monoklinisch kristallinen struktur enthaltenden tabletten oder dragee zusammensetzung.
HUT49793A (en) Herbicide compositions containing n-aryl-tetrahydro-phtalimides as active components and process for producing the active components
DE69433012D1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
DE68924373D1 (de) Verfahren zur Herstellung konzentrierter Granulatkörner von oberflächenaktiven Mitteln.
ATE122382T1 (de) Verfahren zur herstellung von zeolith-granulaten.
HUT52763A (en) Herbicide and growth-controlling compositions containing sulfonyl-urea derivatives as active components and process for producing the active components
ZA898921B (en) 2-azabicyclo(2.2.1)herp-5-ene-2-acetic acid,derivatives thereof and related compounds,process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine
JPS51151743A (en) Process for preparing shaped polyester article
JPS57170165A (en) Active calcium fortifier
HUT59903A (en) Fungicide compositions containing oxime-carbamates as active components and process for producing the active components
HU913009D0 (en) Method for producing inhibitors of calcium ingestion
HUT55604A (en) Fungicide and growth-controlling compositions containing n-oxo-azolyl-methyl-oxiranes as active components and process for producing the active components
HUT56069A (en) Fungicide composition sontaining pyridyl-cyclopropane-amines as active components and process for producing the active components

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee